Science in the service of humanity: Princeton joins Rutgers, NJIT to advance health-related innovations

Princeton faculty and student researchers make many discoveries that have the potential to address cancer, infectious disease, autism and other development disorders, and other medical, behavioral and health challenges. Now, a collaboration with Rutgers University and the New Jersey Institute of Technology is making it easier and faster for Princeton’s medical and health-related research to reach patients and the community. The collaboration, known as the New Jersey Alliance for Clinical and Translational Science (NJ ACTS), began in 2019 and is funded by a $29 million grant from the National Institutes of Health to speed the translation of research into innovations that can lead to improvements in patient and public health.